BALTIMORE, MD, UNITED STATES, September 30, 2025 /EINPresswire.com/ -- EpiWatch, Inc. today announced that its app-based product, EpiWatch, an FDA-cleared and ...
A study found that most individuals diagnosed with focal epilepsy take over a year and more than one medication to be free of seizures. The study, led by researchers from the U.S. and Australia and ...
Shares of Praxis Precision Medicines jumped after the company announced positive topline results for a Phase 2 study of its seizure medication vormatrigine. The stock was up 15% at $62 in premarket ...
Shares of Rapport Therapeutics surged after the company said a trial of its seizure treatment met its primary endpoint. The stock more than doubled in premarket trading to $35.20. The Boston company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback